CH566289A5 - - Google Patents

Info

Publication number
CH566289A5
CH566289A5 CH1342873A CH1342873A CH566289A5 CH 566289 A5 CH566289 A5 CH 566289A5 CH 1342873 A CH1342873 A CH 1342873A CH 1342873 A CH1342873 A CH 1342873A CH 566289 A5 CH566289 A5 CH 566289A5
Authority
CH
Switzerland
Application number
CH1342873A
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of CH566289A5 publication Critical patent/CH566289A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrrole Compounds (AREA)
CH1342873A 1969-12-18 1970-12-15 CH566289A5 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1178769A AT305987B (de) 1969-12-18 1969-12-18 Verfahren zur Herstellung von neuen Aminoketonen

Publications (1)

Publication Number Publication Date
CH566289A5 true CH566289A5 (zh) 1975-09-15

Family

ID=3630679

Family Applications (4)

Application Number Title Priority Date Filing Date
CH1342873A CH566289A5 (zh) 1969-12-18 1970-12-15
CH1342973A CH566290A5 (zh) 1969-12-18 1970-12-15
CH1859570A CH566963A5 (zh) 1969-12-18 1970-12-15
CH1342773A CH566288A5 (zh) 1969-12-18 1970-12-15

Family Applications After (3)

Application Number Title Priority Date Filing Date
CH1342973A CH566290A5 (zh) 1969-12-18 1970-12-15
CH1859570A CH566963A5 (zh) 1969-12-18 1970-12-15
CH1342773A CH566288A5 (zh) 1969-12-18 1970-12-15

Country Status (16)

Country Link
JP (1) JPS5245701B1 (zh)
AT (1) AT305987B (zh)
BE (1) BE760505A (zh)
CA (1) CA992979A (zh)
CH (4) CH566289A5 (zh)
DE (1) DE2061864C3 (zh)
DK (1) DK137380B (zh)
ES (3) ES385918A1 (zh)
FI (1) FI53700C (zh)
FR (1) FR2081381B1 (zh)
GB (1) GB1332930A (zh)
NL (1) NL164552C (zh)
SE (1) SE383874B (zh)
SU (3) SU470108A3 (zh)
YU (1) YU35434B (zh)
ZA (1) ZA708151B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305960A (en) 1980-01-25 1981-12-15 Shell Oil Company N-Phenethylaminopropiophenones as lipogenesis inhibitors
US4279929A (en) 1980-01-25 1981-07-21 Shell Oil Company N-Phenethylaminopropiophenones as lipogenesis inhibitors
US4276307A (en) 1980-01-25 1981-06-30 Shell Oil Company N-Phenethylaminopropiophenones as lipogenesis inhibitors
US4279925A (en) 1980-01-25 1981-07-21 Shell Oil Company N-Phenethylaminopropiophenones as lipogenesis inhibitors
US4285970A (en) 1980-01-25 1981-08-25 Shell Oil Company N-Phenethylaminopropiophenones as lipogenesis inhibitors
IL156669A0 (en) 2003-06-26 2004-01-04 Neurim Pharma 1991 2-aminobenzoyl derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6609318A (zh) * 1966-07-04 1968-01-05

Also Published As

Publication number Publication date
ES395209A1 (es) 1975-03-01
CH566290A5 (zh) 1975-09-15
CA992979A (en) 1976-07-13
NL164552C (nl) 1981-01-15
NL7017884A (zh) 1971-06-22
SU493956A3 (ru) 1975-11-28
AT305987B (de) 1973-03-26
FI53700C (fi) 1978-07-10
ES395207A1 (es) 1975-03-16
DE2061864B2 (de) 1979-06-28
JPS5245701B1 (zh) 1977-11-17
FR2081381B1 (zh) 1974-03-22
ZA708151B (en) 1971-12-29
FI53700B (zh) 1978-03-31
DE2061864C3 (de) 1980-03-13
YU35434B (en) 1981-02-28
DK137380C (zh) 1978-07-31
DK137380B (da) 1978-02-27
GB1332930A (en) 1973-10-10
YU292770A (en) 1980-06-30
ES385918A1 (es) 1973-05-01
SE383874B (sv) 1976-04-05
FR2081381A1 (zh) 1971-12-03
SU507224A3 (ru) 1976-03-15
CH566288A5 (zh) 1975-09-15
BE760505A (fr) 1971-05-27
SU470108A3 (ru) 1975-05-05
NL164552B (nl) 1980-08-15
DE2061864A1 (zh) 1971-10-14
SU440826A3 (zh) 1974-08-25
CH566963A5 (zh) 1975-09-30

Similar Documents

Publication Publication Date Title
AU465413B2 (zh)
AU450150B2 (zh)
AU442375B2 (zh)
AU470301B1 (zh)
AU5113869A (zh)
AU442380B2 (zh)
AU442554B2 (zh)
SU440826A3 (zh)
AU470661B1 (zh)
AU442538B2 (zh)
AU442463B2 (zh)
AU442357B2 (zh)
AU442535B2 (zh)
AU5109569A (zh)
AU5228269A (zh)
CS148366B1 (zh)
CS148360B1 (zh)
CS149254B1 (zh)
AU4949169A (zh)
CS148146B2 (zh)
AU4540468A (zh)
BR6914896D0 (zh)
AU5077469A (zh)
AU469091A (zh)
BE738779A (zh)

Legal Events

Date Code Title Description
PL Patent ceased